Recent Headlines
The U.S. Food and Drug Administration is alerting consumers of a voluntary recall by Johnson & Johnson of Johnson's Baby Powder after FDA testing has found that a sample from one lot of the product contains chrysotile fibers, a ty (full story)
JNJ: 127.70 (-8.47)
In recent years the pharmaceutical and cosmetics giant Johnson & Johnson has been facing a slew of lawsuits related to allegations that its popular talc-based products can cause cancer. Women have filed lawsuits claiming that they (full story)
JNJ: 127.70 (-8.47)
U.S. markets primarily focused on the earnings season as banks kicked off the week. On Monday, markets remained relatively flat as investors continued to remain skeptical of a potential trade agreement between the U.S. and China. (full story)
JNJ: 127.70 (-8.47), JPM: 120.56 (+0.21), UNH: 245.34 (+1.67), BAC: 30.35 (+0.09), NFLX: 275.30 (-18.05), IBM: 134.09 (-0.17)
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing auth (full story)
JNJ: 127.70 (-8.47)
Out of an abundance of caution, Johnson & Johnson Consumer Inc. (JJCI) announced that it is initiating a voluntary recall in the United States of a single lot of its Johnson's Baby Powder in response to a U.S. Food and Drug Admini (full story)
JNJ: 127.70 (-8.47)
Performance Comparison
| Name | Today | 3-Month | 1-Year |
| JNJ |
 -6.22% |
 -3.02% |
-8.46% |
Growth Rates
| YTD | -1.05% | |||
| 1-Year | -8.16% | |||
| 3-Year | +12.57% | |||
| 5-Year | +23.82% | |||
| 10-Year | +116.26% |